These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 26754878

  • 1. A new vinyl selenone-based domino approach to spirocyclopropyl oxindoles endowed with anti-HIV RT activity.
    Palomba M, Rossi L, Sancineto L, Tramontano E, Corona A, Bagnoli L, Santi C, Pannecouque C, Tabarrini O, Marini F.
    Org Biomol Chem; 2016 Feb 14; 14(6):2015-24. PubMed ID: 26754878
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of human immunodeficiency virus type (HIV-1) replication by some diversely functionalized spirocyclopropyl derivatives.
    Witvrouw M, Pannecouque C, De Clercq E, Fernández-Alvarez E, Marco JL.
    Arch Pharm (Weinheim); 1999 May 14; 332(5):163-6. PubMed ID: 10366901
    [Abstract] [Full Text] [Related]

  • 3. "Second generation" of TSAO compounds directed against HIV-1 TSAO-resistant strains.
    Lobatón E, Velázquez S, Pérez-Pérez MJ, Jimeno ML, San-Félix A, De Clercq E, Balzarini J, Camarasa MJ.
    Nucleosides Nucleotides Nucleic Acids; 2001 May 14; 20(4-7):707-10. PubMed ID: 11563097
    [Abstract] [Full Text] [Related]

  • 4. Abasic analogues of TSAO-T as the first sugar derivatives that specifically inhibit HIV-1 reverse transcriptase.
    Velázquez S, Chamorro C, Pérez-Pérez MJ, Alvarez R, Jimeno ML, Martín-Domenech A, Pérez C, Gago F, De Clercq E, Balzarini J, San-Félix A, Camarasa MJ.
    J Med Chem; 1998 Nov 05; 41(23):4636-47. PubMed ID: 9804703
    [Abstract] [Full Text] [Related]

  • 5. Regiospecific synthesis and anti-human immunodeficiency virus activity of novel 5-substituted N-alkylcarbamoyl and N,N-dialkylcarbamoyl 1,2,3-triazole-TSAO analogues.
    Velázquez S, Alvarez R, Pérez C, Gago F, De Clercq E, Balzarini J, Camarasa MJ.
    Antivir Chem Chemother; 1998 Nov 05; 9(6):481-9. PubMed ID: 9865386
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of HIV-1 Reverse Transcriptase Dimerization by Small Molecules.
    Tintori C, Corona A, Esposito F, Brai A, Grandi N, Ceresola ER, Clementi M, Canducci F, Tramontano E, Botta M.
    Chembiochem; 2016 Apr 15; 17(8):683-8. PubMed ID: 26946324
    [Abstract] [Full Text] [Related]

  • 7. Novel indole based NNRTIs with improved potency against wild type and resistant HIV.
    Müller R, Mulani I, Basson AE, Pribut N, Hassam M, Morris L, van Otterlo WAL, Pelly SC.
    Bioorg Med Chem Lett; 2014 Sep 15; 24(18):4376-4380. PubMed ID: 25176191
    [Abstract] [Full Text] [Related]

  • 8. Novel indole sulfides as potent HIV-1 NNRTIs.
    Brigg S, Pribut N, Basson AE, Avgenikos M, Venter R, Blackie MA, van Otterlo WAL, Pelly SC.
    Bioorg Med Chem Lett; 2016 Mar 15; 26(6):1580-1584. PubMed ID: 26876929
    [Abstract] [Full Text] [Related]

  • 9. Design, synthesis and pharmacological evaluation of HIV-1 reverse transcriptase inhibition of new indolin-2-ones.
    Boechat N, Kover WB, Bongertz V, Bastos MM, Romeiro NC, Azevedo ML, Wollinger W.
    Med Chem; 2007 Nov 15; 3(6):533-42. PubMed ID: 18045202
    [Abstract] [Full Text] [Related]

  • 10. Novel N-3 substituted TSAO-T derivatives: synthesis and anti-HIV-evaluation.
    Bonache MC, Quesada E, Sheen CW, Balzarini J, Sluis-Cremer N, Pérez-Pérez MJ, Camarasa MJ, San-Félix A.
    Nucleosides Nucleotides Nucleic Acids; 2008 Apr 15; 27(4):351-67. PubMed ID: 18404570
    [Abstract] [Full Text] [Related]

  • 11. Hit optimization studies of 3-hydroxy-indolin-2-one analogs as potential anti-HIV-1 agents.
    Chander S, Tang CR, Penta A, Wang P, Bhagwat DP, Vanthuyne N, Albalat M, Patel P, Sankpal S, Zheng YT, Sankaranarayanan M.
    Bioorg Chem; 2018 Sep 15; 79():212-222. PubMed ID: 29775947
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1.
    Wu B, Kuhen K, Ngoc Nguyen T, Ellis D, Anaclerio B, He X, Yang K, Karanewsky D, Yin H, Wolff K, Bieza K, Caldwell J, He Y.
    Bioorg Med Chem Lett; 2006 Jul 01; 16(13):3430-3. PubMed ID: 16632349
    [Abstract] [Full Text] [Related]

  • 13. Discovery of TSAO derivatives with an unusual HIV-1 activity/resistance profile.
    de Castro S, García-Aparicio C, Van Laethem K, Gago F, Lobatón E, De Clercq E, Balzarini J, Camarasa MJ, Velázquez S.
    Antiviral Res; 2006 Aug 01; 71(1):15-23. PubMed ID: 16616962
    [Abstract] [Full Text] [Related]

  • 14. From human immunodeficiency virus non-nucleoside reverse transcriptase inhibitors to potent and selective antitrypanosomal compounds.
    Venkatraj M, Ariën KK, Heeres J, Joossens J, Dirié B, Lyssens S, Michiels J, Cos P, Lewi PJ, Vanham G, Maes L, Van der Veken P, Augustyns K.
    Bioorg Med Chem; 2014 Oct 01; 22(19):5241-8. PubMed ID: 25199582
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and biological evaluation of N4-(hetero)arylsulfonylquinoxalinones as HIV-1 reverse transcriptase inhibitors.
    Xu B, Sun Y, Guo Y, Cao Y, Yu T.
    Bioorg Med Chem; 2009 Apr 01; 17(7):2767-74. PubMed ID: 19269831
    [Abstract] [Full Text] [Related]

  • 16. Design, synthesis and molecular docking of pyrazolo [3,4d] thiazole hybrids as potential anti-HIV-1 NNRT inhibitors.
    Kasralikar HM, Jadhavar SC, Goswami SV, Kaminwar NS, Bhusare SR.
    Bioorg Chem; 2019 May 01; 86():437-444. PubMed ID: 30771690
    [Abstract] [Full Text] [Related]

  • 17. Identification of a putative binding site for [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine (TSAO) derivatives at the p51-p66 interface of HIV-1 reverse transcriptase.
    Rodríguez-Barrios F, Pérez C, Lobatón E, Velázquez S, Chamorro C, San-Félix A, Pérez-Pérez MJ, Camarasa MJ, Pelemans H, Balzarini J, Gago F.
    J Med Chem; 2001 Jun 07; 44(12):1853-65. PubMed ID: 11384232
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and biological evaluation of novel 5-alkyl-2-arylthio-6-((3,4-dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Zhang J, Zhan P, Wu J, Li Z, Jiang Y, Ge W, Pannecouque C, De Clercq E, Liu X.
    Bioorg Med Chem; 2011 Jul 15; 19(14):4366-76. PubMed ID: 21683601
    [Abstract] [Full Text] [Related]

  • 19. Design, synthesis and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part I.
    Jiang T, Kuhen KL, Wolff K, Yin H, Bieza K, Caldwell J, Bursulaya B, Wu TY, He Y.
    Bioorg Med Chem Lett; 2006 Apr 15; 16(8):2105-8. PubMed ID: 16480865
    [Abstract] [Full Text] [Related]

  • 20. 4"-H-TSAO-T, a novel prototype in the HIV-1 specific TSAO family.
    Lobatón E, Velázquez S, San-Félix A, De Clercq E, Balzarini J, Camarasa MJ.
    Nucleosides Nucleotides Nucleic Acids; 2001 Apr 15; 20(4-7):711-4. PubMed ID: 11563098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.